In addition, Gal-1 has been shown to be involved with improved muscle function and sarcolemma integrity in murine models of muscular dystrophy, confirming that Gal-1 contributes to improved body composition in patients receiving enriched ONS, increasing the anabolic status of muscle mass [17,18]. The gene discussed is LGALS1; the disease is muscular dystrophy.